The Phenotypic Continuum of ATP1A3-Related DisordersNeurol 99:e1511-e1526, Vezyroglou,A., et al, 2022
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine AgonistsClin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986